The vitamin D receptor regulates rheumatoid arthritis synovial fibroblast invasion and morphology

Molecular Medicine

Volumn 18, Issue 2, 2012, Pages 194-200

  Laragione, Teresina ^a   Shah, Anish ^a   Gulko, Pércio S ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b Elmezzi Graduate School of Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CALCITRIOL; COLLAGEN; ETANERCEPT; FOCAL ADHESION KINASE; INTERSTITIAL COLLAGENASE; PRISTANE; VITAMIN D RECEPTOR;

ACTIN FILAMENT; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MOTILITY; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; LAMELLIPODIUM; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; TRANSCRIPTION REGULATION; ZYMOGRAPHY;

AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CALCITRIOL; FEMALE; FIBROBLASTS; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; RATS; RECEPTORS, CALCITRIOL; SYNOVIAL MEMBRANE;

EID: 84859038758     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00410     Document Type: Article

References (41)

1. Seldin MF, Amos CI, Ward R, Gregersen PK. (1999) The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 42:1071-9.
2. Gulko PS, Winchester RJ. (2001) Rheumatoid arthritis. In: Samter's Immunologic Diseases. Austen KF, Frank MM, Atkinson JP, Cantor H (eds.) Lippincott, Williams & Wilkins, Baltimore, MD, pp. 427-63.
3. Wolfe F, et al. (1994) The mortality of rheumatoid arthritis. Arthritis Rheum. 37:481-94.
4. Gossec L, et al. (2004) Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann. Rheum. Dis. 63:675-80.
5. Brenner M, Linge CP, Li W, Gulko PS. (2011) Increased synovial expression of nuclear receptors correlates with arthritis protection: a possible novel genetically regulated homeostatic mechanism. Arthritis Rheum. 63:2918-29.
6. Tuckey RC, et al. (2008) Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J. 275:2585-96.
7. Schuster I. (2011) Cytochromes P450 are essential players in the vitamin D signaling system. Biochim. Biophys. Acta. 1814:186-99.
8. Kerr GS, et al. (2011) Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J. Rheumatol. 38:53-9.
9. Rossini M, et al. (2010) Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res. Ther. 12:R216.
10. Craig SM, et al. (2010) Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J. Rheumatol. 37:275-81.
11. Moghaddami M, et al. (2011) Efficacy and mechanisms of action of vitamin D in experimental polyarthritis. Immunol. Cell. Biol. 2011, Mar 29 [Epub ahead of print].
12. Cantorna MT, Hayes CE, DeLuca HF. (1998) 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr. 128:68-72.
13. Szeto FL, et al. (2007) Involvement of the vitamin D receptor in the regulation of NF-kappaB activity in fibroblasts. J. Steroid. Biochem. Mol. Biol. 103:563-6.
14. Tetlow LC, Woolley DE. (1999) The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion. Arthritis Res. 1:63-70.
15. Colin EM, et al. (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 62:132-42.
16. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE. (2007) Modulatory effects of 1,25-dihydroxy-vitamin D3 on human B cell differentiation. J. Immunol. 179:1634-47.
17. Muller-Ladner U, et al. (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149:1607-15.
18. Bartok B, Firestein GS. (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol. Rev. 233:233-55.
19. van der Heijde D, Landewe R, van Vollenhoven R, Fatenejad S, Klareskog L. (2008) Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial. Ann. Rheum. Dis. 67:1267-70.
20. Laragione T, Brenner M, Mello A, Symons M, Gulko PS. (2008) The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts. Arthritis Rheum. 58:2296-306.
21. Tolboom TC, et al. (2005) Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 52:1999-2002.
22. Vingsbo C, et al. (1996) Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am. J. Pathol. 149:1675-83.
23. Brenner M, et al. (2005) The non-MHC quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation and joint damage. Arthritis Rheum. 52:322-32.
24. Arnett FC, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315-24.
25. Laragione T, Gulko PS. (2010) mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol. Med. 16:352-8.
26. Laragione T, Brenner M, Sherry B, Gulko PS. (2011) CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis. Arthritis Rheum. 63:3274-83.
27. Livak KJ, Schmittgen TD. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) method. Methods. 25:402-8.
28. van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. (1993) Factors predicting outcome of rheumatoid arthritis: results of a followup study. J. Rheumatol. 20:1288-96.
29. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL. (2001) The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum. 44:2009-17.
30. Drossaers-Bakker KW, et al. (1999) Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum. 42:1854-60.
31. Combe B, et al. (2001) Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. Arthritis Rheum. 44:1736-43.
32. Boissier MC, Chiocchia G, Fournier C. (1992) Combination of cyclosporine A and calcitriol in the treatment of adjuvant arthritis. J. Rheumatol. 19:754-7.
33. Tsuji M, Fujii K, Nakano T, Nishii Y. (1994) 1 Alpha-hydroxyvitamin D3 inhibits type II collagen-induced arthritis in rats. FEBS Lett. 337:248-50.
34. Larsson P, Mattsson L, Klareskog L, Johnsson C. (1998) A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin. Exp. Immunol. 114:277-83.
35. Cunnane G, et al. (2001) Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum. 44:1744-53.
36. Machesky LM. (2008) Lamellipodia and filopodia in metastasis and invasion. FEBS Lett. 582:2102-11.
37. Smith SJ, Hayes ME, Selby PL, Mawer EB. (1999) Autocrine control of vitamin D metabolism in synovial cells from arthritic patients. Ann. Rheum. Dis. 58:372-8.
38. Sung V, Feldman D. (2000) 1,25-Dihydroxy-vitamin D3 decreases human prostate cancer cell adhesion and migration. Mol. Cell. Endocrinol. 164:133-43.
39. Sundaram S, et al. (2006) QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells. Mol. Cancer Ther 5:2806-14.
40. Palmer HG, et al. (2001) Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell. Biol. 154:369-87.
41. Tokar EJ, Webber MM. (2005) Cholecalciferol (vitamin D3) inhibits growth and invasion by upregulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin. Exp. Metastasis. 22:275-84.